By Denny JacobMerck received approval from the Food and Drug Administration for cancer drug Keytruda in combination with chemoradiotherapy as a treatment for patients with FIGO 2014 Stage III-IVA cervical cancer. The healthcare company said the approval marks the third indication for keytruda in cervical cancer and the 39th indication for keytruda in the United States.

Source: Wall Street Journal January 13, 2024 10:41 UTC